Hypoglycemia supportive therapy is the stepwise care given to raise and stabilize blood glucose when it falls below 70 mg/dL. It ranges from 15 grams of oral carbohydrate at home to intravenous dextrose, intramuscular glucagon, and octreotide in the emergency department. The right level depends on severity, cause, and whether the person is awake.
How Hypoglycemia Is Classified
Treatment intensity follows the severity of the low. The American Diabetes Association uses a three-level system that drives every decision in supportive care.
| Level | Glucose | Symptoms | Typical Therapy |
|---|---|---|---|
| Level 1 (alert value) | 54-70 mg/dL | Shaky, sweaty, hungry; person can self-treat | Oral carbs, 15-15 rule |
| Level 2 (clinically significant) | Below 54 mg/dL | Confusion, blurred vision, weakness | Oral if able; otherwise IV dextrose or glucagon |
| Level 3 (severe) | Any value with altered mental status | Seizure, unconsciousness, unable to swallow | Glucagon, IV D50W, hospital observation |
Step 1: At-Home Oral Carbohydrate (The 15-15 Rule)
For an alert person with mild to moderate hypoglycemia, the first-line supportive therapy is 15 grams of fast-acting glucose. Recheck blood sugar in 15 minutes. If still under 70 mg/dL, repeat. Once stable, eat a snack with protein and complex carbs to prevent rebound.
Reliable 15-gram options include 4 glucose tablets, 4 ounces of juice or regular soda, 1 tablespoon of honey, or 8 ounces of skim milk. Avoid foods with fat such as chocolate or peanut butter — fat slows absorption and delays recovery. For more on at-home protocols, see our guide on hypoglycemia treatment.
Step 2: Glucagon for the Unconscious Patient
When someone cannot swallow safely, glucagon is the primary at-home rescue therapy. Glucagon mobilizes liver glycogen and raises blood glucose within 10-15 minutes. Three FDA-approved forms exist:
- Nasal glucagon (Baqsimi): 3 mg single-dose dry-powder spray; works regardless of breathing pattern.
- Pre-mixed pen (Gvoke HypoPen): 1 mg subcutaneous injection, ready-to-use.
- Traditional emergency kit: Lyophilized powder reconstituted with diluent before injection.
After glucagon, place the person on their side (recovery position), call 911, and offer fast-acting carbs once they are awake and alert. Glucagon may cause nausea and vomiting, so an oral carb chaser is essential to prevent a second drop.
Step 3: IV Dextrose in the Emergency Department
Intravenous dextrose is the hospital standard for severe hypoglycemia. Standard adult dosing is 25 grams of 50% dextrose (D50W, one ampule) given by slow IV push through a large vein. Pediatric dosing uses D25W or D10W to avoid sclerosing small veins.
If hypoglycemia recurs after the bolus — common with insulin overdose, sulfonylureas, alcohol, or hepatic failure — clinicians start a continuous D10W infusion at 75-100 mL/hr and titrate to maintain glucose between 100 and 180 mg/dL. Bedside glucose checks every 15-30 minutes guide the drip rate.
Step 4: Octreotide for Sulfonylurea-Induced Hypoglycemia
Sulfonylureas (glipizide, glyburide, glimepiride) stimulate pancreatic beta cells to release insulin. Giving dextrose alone in this setting paradoxically triggers more insulin secretion and recurrent lows. Octreotide, a long-acting somatostatin analog, blocks beta-cell insulin release and is the targeted antidote.
Typical adult dosing is 50-100 mcg subcutaneously every 6-8 hours for at least 24 hours. Patients usually require admission for monitoring because sulfonylurea half-lives can exceed 24 hours in older adults and those with renal disease.
Continuous Glucose Monitoring During Recovery
Any patient with prolonged, recurrent, or unexplained hypoglycemia receives continuous monitoring. In the hospital this means bedside fingersticks every 15-60 minutes initially. After discharge, a continuous glucose monitor (CGM) such as Dexcom G7 or FreeStyle Libre 3 alerts the patient before lows recur.
The ADA now recommends CGM for any insulin-treated patient who has experienced a level 2 or level 3 event. Early data show CGM use cuts severe hypoglycemia by roughly 50% in this population.
Hospital Admission vs. Outpatient Discharge
| Discharge Home | Admit for Observation |
|---|---|
| Single insulin-related episode, fully resolved | Sulfonylurea or long-acting insulin overdose |
| Identifiable, correctable cause (missed meal) | Recurrent lows after initial treatment |
| Reliable caregiver and home glucose meter | Renal failure, sepsis, hepatic dysfunction |
| Glucose stable above 100 mg/dL for 4 hours | Altered mental status that does not fully clear |
| Patient understands and can follow up | Suicide attempt or intentional overdose |
Special Cases in Supportive Care
Alcohol-Related Hypoglycemia
Heavy alcohol use blocks gluconeogenesis. Treat with IV dextrose plus thiamine 100 mg IV before glucose to prevent Wernicke’s encephalopathy in malnourished patients.
Insulinoma or Endogenous Hyperinsulinism
Recurrent fasting hypoglycemia without diabetes drugs requires endocrine workup. Diazoxide can suppress insulin secretion until surgical resection or definitive diagnosis.
Post-Bariatric Hypoglycemia
Reactive lows 1-3 hours after meals respond to small, low-glycemic meals, acarbose, or in refractory cases, octreotide.
Preventing the Next Episode
Supportive therapy does not end when the glucose normalizes. Every hypoglycemia event triggers a medication review, education on the A1C vs. glucose relationship, and a check on the patient’s diet — see our prediabetes diet guide for meal-timing strategies that prevent recurrent lows.
According to the CDC, severe hypoglycemia accounts for an estimated 235,000 emergency department visits annually in the United States — most are preventable with proper insulin titration and CGM use.
The Bottom Line
Hypoglycemia supportive therapy is a ladder. Start with 15 grams of oral glucose for an alert patient, escalate to glucagon if consciousness is impaired, and move to IV dextrose with continuous monitoring in the hospital. Add octreotide whenever a sulfonylurea is involved. The goal is not just to raise blood sugar once — it is to find the cause, prevent the next episode, and keep glucose stable long enough for the body and the offending drug to clear.
